As suggested by several studies, abnormal sensory gating measured by the P50 paradigm could be an endophenotype predisposing to schizophrenia. In a previous work, we have shown a significant association between the presence of at least one À2 bp deletion located within exon 6 of the CHRNA7-like gene and the P50 abnormality in the general population. A recent study involved polymorphisms located in the core promoter region of the CHRNA7 gene as risk factors for the P50 inhibitory deficit. Screening for promoter variants in a large population of schizophrenic patients (n¼111) and control subjects (85), for whom auditoryevoked potentials had been recorded did not allow us to replicate these results. By contrast, we showed a significant association between the À194 C allele and a T/C ratio o0.45, thus demonstrating a protective effect of this variant for the sensory gating deficit. Such conflicting results can be reconciled if we consider that the À194 C polymorphism has no causative effect, but is in linkage disequilibrium with other causal variations for the P50 sensory gating deficit, and that different alleles are in disequilibrium in different populations.
Several lines of evidence suggest that the deficit in the inhibition of the P50-evoked response to repeated auditory stimuli measured by the T/C ratio could be an inherited trait predisposing to schizophrenia. 1 Biochemical and genetic studies suggest that the alpha 7 nicotinic receptor may function in an inhibitory neuronal pathway involved in this phenomenon. 2 The P50 sensory gating deficit was genetically linked to 15q13-14. 3 Two related alpha 7 gene (ie CHRNA7 and CHRNA7-like genes) located 1 Mb apart and resulting from a partial duplication of an ancestral gene map in this chromosomal region. 4 In a previous work, we have shown that the presence of at least one À2 bp deletion located in exon 6 of the CHRNA7-like gene is a risk factor for P50 abnormality in the general population. 5 Recently, Leonard et al 6 identified several polymorphisms in a core promoter region of the CHRNA7 gene. They showed that most of these variations result in a decreased transcription by using the luciferase reporter gene assay, and they reported a significantly greater prevalence of functional promoter variants in subjects who had an inhibitory deficit. In order to replicate these results in a large population of schizophrenic patients and control subjects, for whom auditory-evoked potentials had been recorded, we compared the distribution of the CHRNA7 core promoter region polymorphisms between 111 schizophrenic patients and 85 control subjects who were classified according to their P50 T/C ratio value.
As shown in Table 1 , 22% of control subjects as compared with 88% of schizophrenic patients had abnormal gating defined by a T/C ratio 40.5. Thus, although some studies using slightly different procedures were unable to replicate previous findings on abnormal P50 suppression in schizophrenic patients, 7, 8 this study confirm the basic results of Freedman et al. 1 Sequencing of the 231 bp upstream the CHRNA7 translation initiation site revealed three different polymorphisms, the distribution of which is shown in Table 2 . All variants were found at the heterozygous state except in one schizophrenic patient who was homozygous for the À86T substitution. Only one control subject had a double variant (À86 C/T and À194 G/C).
In accordance with the data from Leonard et al, 6 two variants were found to be more common in the white population: the subjects carrying the À194 G/C polymorphism and the À86 C/T polymorphism account for 91% of the subjects carrying at least one polymorphism. We analysed separately these two polymorphisms. The distribution of the À86 C/T polymorphism did not significantly differ between subjects with normal and abnormal T/C ratio. In contrast, we found a significant association (w 2 ¼5.14; df¼1, Po0.02) between the À194 C allele and a T/C ratio o0.45 (Table 3) . Thus, the presence of this polymorphism is protective for the sensory gating deficit. This finding is clearly inconsistent with the results of Leonard et al, 6 who found an association between the CHRNA7 promoter variants and higher P50 ratio in control subjects. However, these conflicting results can be reconciled if we consider that the À194 G/C polymorphism is not causative, but is in linkage disequilibrium with other causal variations for the P50 sensory gating deficit, and that different alleles are in disequilibrium in different populations. It is interesting to note that the effect of the À194 C allele on the transcriptional activity of the CHRNA7 gene is very weak, which argues against a direct role.
Material and methods

Patients
Unrelated schizophrenics patients (n¼111) were included in this study (32 females and 79 males aged 29.477.8 years). Diagnoses were made according to DSM IV 9 criteria by two trained psychiatrists after clinical interviews, using the Schizophrenia Disorders Lifetime Version (SADS-LA 10 ). The control sample included 45 females and 40 males (aged 36.279.5 years) free of personal and familial history of neurological or psychiatric disease. Control subjects were free of any psychotropic treatment, whereas all schizophrenic patients received typical neuroleptic treatments. All subjects were French Caucasians originating from Normandy. All subjects gave written informed consent for genetic study and electrophysiological recording.
Electrophysiological recording
Electroencephalographic activity was recorded as described previously, 5, 11 and according to the P50 suppression paradigm. 12,13. Auditory stimuli were delivered in a conditioning-testing paradigm. Click pairs (C, conditioning click; T, testing click; 500 ms interclick interval) were delivered with a fixed interpair interval of 10 s. A series of paired clicks were presented through a set of headphones. The intensity of the clicks was adjusted to 100 db. Evoked potential signals were collected from electrodes placed at the vertex. The amplitude of P50 was defined as the absolute difference between the most positive peak within the specified range after click onset and the preceding negative peak. The latency was measured as the time delay to peak onset after the stimulus. The gating of the P50 wave was calculated as the ratio (T/C) of the amplitude of the testing response (T) to the amplitude of the conditioning response (C). Subjects with values between 0.45 and 0.50 (three schizophrenic patients) were not included in the study.
Molecular analysis
To investigate the core promoter region of the CHRNA7 gene, we amplified and sequenced this region using a primer set described by Leonard et al 6 and the same PCR conditions: sense primer was 5 0 AGTACCTCCCGCTCACACCTCG3 0 ; and antisense primer was 5 0 ATGTTGAGTCCCGGAGCTGCAG 3 0 ; the size of the amplicon was 271 bp. Mutation screening was performed on an Applied Biosystems model 377XL automated sequencer (Applied Biosystems, Foster City, CA, USA).
Statistical methods w 2 tests were used for genotype distribution comparisons (using the Yates correction if necessary).
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